The Natural History of Minimally Symptomatic Nonobstructing Calyceal Stones
1 other identifier
observational
96
1 country
1
Brief Summary
- The primary aim is to study the natural history of single-calyx asymptomatic nonobstructing stone disease.
- The Secondary aim is to determine the predictors of the need for intervention and of cure in such population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2019
CompletedFirst Posted
Study publicly available on registry
August 28, 2019
CompletedStudy Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedJuly 23, 2025
July 1, 2025
4.8 years
August 25, 2019
July 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
study the natural history of single-calyx asymptomatic nonobstructing stone disease
Time to events indicating the need for intervention or cure
Baseline
Interventions
non-contrast multi-slice computed tomography
Abdominal ultrasonography
Urine analysis
Urine culture
Eligibility Criteria
Patients attending the outpatient clinic of urolithiasis in Assiut Urology and Nephrology Hospital.
You may qualify if:
- Cases older than 18 years with renal stone disease affecting no more than one major calyx and causing neither obstruction nor bothersome pain.
- We define calyceal obstruction as calyceal dilatation with stone impaction at the calyceal neck.
- If the stones are not impacted or are casting the calyx, they are not considered obstructing.
You may not qualify if:
- Gross or microscopic hematuria.
- Patients who have difficulty to reach our tertiary center for follow-up.
- Other pathology in the target uretero-renal unit that requires intervention, e.g., ureteropelvic junction obstruction, malignancies, ureteric stones, …etc.
- History of recurrent urinary tract infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University Hospital
Asyut, Egypt
Related Publications (11)
Shoag J, Tasian GE, Goldfarb DS, Eisner BH. The new epidemiology of nephrolithiasis. Adv Chronic Kidney Dis. 2015 Jul;22(4):273-8. doi: 10.1053/j.ackd.2015.04.004.
PMID: 26088071BACKGROUNDLechevallier E, Traxer O, Saussine C. [Open surgery for upper urinary tract stones]. Prog Urol. 2008 Dec;18(12):952-4. doi: 10.1016/j.purol.2008.09.013. Epub 2008 Oct 16. French.
PMID: 19033059BACKGROUNDLopez M, Hoppe B. History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol. 2010 Jan;25(1):49-59. doi: 10.1007/s00467-008-0960-5.
PMID: 21476230BACKGROUNDMatlaga BR, Assimos DG. Changing indications of open stone surgery. Urology. 2002 Apr;59(4):490-3; discussion 493-4. doi: 10.1016/s0090-4295(01)01670-3.
PMID: 11927296BACKGROUNDAlivizatos G, Skolarikos A. Is there still a role for open surgery in the management of renal stones? Curr Opin Urol. 2006 Mar;16(2):106-11. doi: 10.1097/01.mou.0000193379.08857.e7.
PMID: 16479213BACKGROUNDDesai M, Sun Y, Buchholz N, Fuller A, Matsuda T, Matlaga B, Miller N, Bolton D, Alomar M, Ganpule A. Treatment selection for urolithiasis: percutaneous nephrolithomy, ureteroscopy, shock wave lithotripsy, and active monitoring. World J Urol. 2017 Sep;35(9):1395-1399. doi: 10.1007/s00345-017-2030-8. Epub 2017 Mar 16.
PMID: 28303335BACKGROUNDGross AJ, Knipper S, Netsch C. Managing caliceal stones. Indian J Urol. 2014 Jan;30(1):92-8. doi: 10.4103/0970-1591.124214.
PMID: 24497690BACKGROUNDLai D, Chen M, He Y, Li X. Simultaneous retrograde intrarenal surgery for ipsilateral asymptomatic renal stones in patients with ureteroscopic symptomatic ureteral stone removal. BMC Urol. 2015 Mar 19;15:22. doi: 10.1186/s12894-015-0016-7.
PMID: 25888137BACKGROUNDNetsch C, Gross AJ. [Calyceal stones]. Urologe A. 2013 Aug;52(8):1135-45; quiz 1146-8. doi: 10.1007/s00120-013-3239-9. German.
PMID: 23860670BACKGROUNDPorfyris O, Delakas D. Post-extracorporeal shockwave lithotripsy residual stone fragments: clinical significance and management. Scand J Urol Nephrol. 2012 Jun;46(3):188-95. doi: 10.3109/00365599.2011.644861. Epub 2012 Feb 9.
PMID: 22321017BACKGROUNDBoyce CJ, Pickhardt PJ, Lawrence EM, Kim DH, Bruce RJ. Prevalence of urolithiasis in asymptomatic adults: objective determination using low dose noncontrast computerized tomography. J Urol. 2010 Mar;183(3):1017-21. doi: 10.1016/j.juro.2009.11.047. Epub 2010 Jan 21.
PMID: 20092842BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ahmed S. Elazab, Professor
Assiut University
- STUDY CHAIR
Mohamed E. Othman, Professor
Assiut University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator (Specialist)
Study Record Dates
First Submitted
August 25, 2019
First Posted
August 28, 2019
Study Start
September 1, 2019
Primary Completion
June 1, 2024
Study Completion
July 1, 2025
Last Updated
July 23, 2025
Record last verified: 2025-07